Here we describe a case review of a 61-year-old female who developed a Surgicel® granuloma following a partial nephrectomy for clear cell carcinoma in a single functioning kidney. We discuss the biodynamics of Surgicel®, the challenge of reaching the diagnosis and the implications of a Surgicel® granuloma for patients.
RichardHWKavitaGDougJ, et al. Hemostatic efficacy and tissue reaction of oxidized regenerated cellulose hemostats. Cellulose2013; 20: 537–545
2.
YadongWFangWYudongH.Comparative evaluation of biological performance, biosecurity, and availability of cellulose-based absorbable hemostats. Clin Appl Thromb Hemost2018; 24(4): 566–574.
3.
SomaniBKKasthuriRSShaveRM.Emtage LA Surgicel granuloma mimicking a renal tumour. Surgery2006; 139(3): 451.
4.
AgarwalMMMandalAKAgarwalS, et al. Surgicel granuloma: Unusual cause of ‘recurrent’ mass lesion after laparoscopic nephron-sparing surgery for renal cell carcinoma. Urol2010; 76(2): 334–335.
5.
TefikTSanliOOktarT, et al. Oxidized regenerated cellulose granuloma mimicking recurrent mass lesion after laparoscopic nephron sparing surgery. Int J Surg Case Rep2012; 3(6): 227–230.
6.
MinerviniACampiRSessaF, et al. Positive surgical margins and local recurrence after simple enucleation and standard partial nephrectomy for malignant renal tumors: Systematic review of the literature and meta-analysis of prevalence. Minerva Urol Nefrol2017; 69(6): 523–538.
7.
NaylorKLKimSJMcArthurE, et al. Mortality in incident maintenance dialysis patients versus incident solid organ cancer patients: A population-based cohort. Am J Kidney Dis2019; 73(6): 765–776.
